What did @opcclinic actually say?
Technically, almost nothing. The entire spoken transcript is a lyric from Queen's "I Want It All," which is not a medical claim, a protocol recommendation, or a scientific statement of any kind. The real messaging here lives in the hashtags and caption: that BPC-157 and TB-500 together form a popular, "awesome" combo worth following their page to learn more about. So we're fact-checking the implication, not a direct quote, because there isn't one.
That said, the hashtag "wolverinestack" does a lot of heavy lifting. It conjures rapid, almost supernatural healing, a specific promise that deserves scrutiny. Telehealth clinics promoting peptide stacks through TikTok without explicit clinical context are operating in a gray zone that regulators are watching closely. The framing matters even when the words are borrowed from a rock band.
Does the science back this up?
There is legitimate preclinical research on both peptides, but the human trial data is thin in ways that should matter to anyone considering these compounds. BPC-157 is a synthetic pentadecapeptide derived from a protein found in gastric juice. Animal studies show promising effects on tendon healing, gut repair, and angiogenesis (Chang et al., 2011, Journal of Applied Physiology), but no randomized controlled human trials have been published to date. TB-500, a synthetic fragment of Thymosin Beta-4, has shown wound healing and anti-inflammatory properties in animal models (Goldstein et al., 2012, Annals of the New York Academy of Sciences). Some small human studies on Thymosin Beta-4 itself exist in cardiac contexts, but TB-500 specifically lacks robust human data.
The "stack" concept, combining both, is popular in biohacking communities precisely because the proposed mechanisms are complementary. BPC-157 may promote tendon and gut repair through growth factor pathways; TB-500 may support actin regulation and cell migration. Complementary mechanisms on paper do not automatically equal additive benefit in humans. No peer-reviewed study has examined this combination in people.
What did they get wrong (or right)?
Credit where it's due: they didn't make specific false medical claims in the video itself. Using a music lyric and leaving the audience to read into hashtags is either clever or evasive, depending on your interpretation. The "wolverine stack" framing, however, implies a level of regenerative effect that the available human evidence does not support. That's misleading by association, even without a direct claim.
What's missing is context that a responsible clinic should provide. Neither BPC-157 nor TB-500 is FDA-approved. Both are currently banned by WADA for use in competitive sports (WADA Prohibited List, 2024). Compounded versions vary significantly in purity and concentration depending on the compounding pharmacy. Presenting these as "awesome peptides" without any of that context is not balanced health communication, regardless of what the law technically requires of a 15-second TikTok.
What should you actually know?
If you're considering BPC-157 or TB-500, the honest picture looks like this: the animal data is interesting enough that researchers and clinicians take it seriously. The lack of human RCT data means any clinic telling you exactly what these peptides will do for you is extrapolating well beyond the evidence. That's not automatically disqualifying, but it means the risk-benefit math is yours to do with incomplete information.
Regulatory status also matters. The FDA has signaled concern about compounded peptides, and enforcement actions against compounding pharmacies have increased since 2023. The source and quality of any compounded peptide matters enormously. A peptide from a certified 503B outsourcing facility is not the same product as one from an unvetted vendor, and anyone selling you these without that distinction is skipping a step you should care about.
- Ask any prescribing provider what quality standards their compounding source meets.
- Be skeptical of any clinic that leads with branding like "wolverine stack" before clinical context.
- Understand that neither peptide has FDA approval for any indication.